Gail Rodgers is a partner in DLA Piper's global Litigation practice. She is based in New York and concentrates her practice on investigations and compliance.

Gail Rodgers has spent the majority of her career representing multinational pharmaceutical and medical device companies. Gail focuses her practice on end to end compliance and investigations including regarding bribery and corruption. She has represented multiple Fortune 500 companies in cross border and multi-jurisdictional investigations involving allegations of violations of the Foreign Corrupt Practices Act and the UK Bribery Act. She has extensive experience leading teams for corporate internal and government investigations across the globe.

Gail also conducts proactive global compliance reviews and partners with the business in implementing controls and remediations and evaluating the efficacy of compliance and investigations programs and protocols.  A significant portion of her practice involves providing clients with strategic business advice.

Ms. Rodgers has extensive experience in a wide variety of state and federal litigation, and has focused on pharmaceutical and medical device litigation, including providing strategic advice at each stage of a litigation, managing national discovery teams, depositions, motions practice including Daubert challenges and implementation of national resolution programs. She has represented several of the largest pharmaceutical companies in the world.

Before her legal career, Ms. Rodgers practiced as a Registered Nurse in the Critical Care Units of MD Anderson Cancer Center. Her medical experience provides her and her clients a distinct advantage, as it gives Ms. Rodgers particular insight into complex medical issues, scientific evidence, expert development, depositions of medical fact witnesses and case valuation.

Ms. Rodgers also has significant experience as resolution counsel and has coordinated a team of medical specialists in the evaluation of individual and class action claims, resulting in the resolution of thousands of claims. Relevant engagements include litigation relating to the prescription medications Celebrex and Bextra, Omniscan, Phen-Fen and Propulsid.

Ms. Rodgers handled over a hundred medical malpractice actions against a bankrupt hospital, negotiating dozens of multi-million dollar claims resulting in settlements for a fraction of the amounts claimed or outright dismissals of the claims.

Ms. Rodgers is passionate about pro bono work and has represented asylum applicants almost the entirety of her career.  All of her clients have been successful in their quest to remain in the United States.  She mentors multiple teams of junior associates, typically managing seven or eight cases at a time.  She also has represented prisoners in compassionate release cases.

Ms. Rodgers is equally as passionate about diversity, equity and inclusion as it is a cornerstone of her personal life.  She enjoys mentoring and sponsoring junior attorneys, particularly those who are diverse.  During her decade in leadership of the DRI Drug and Medical Device Committee, she has purposefully and significantly increased the percentage of diverse and women attorneys in leadership as well as the speakers at the DRI Drug and Medical Device Seminar.  She also has actively encouraged young and diverse attorneys to engage with the Committee and work towards leadership roles.